Dr. Reddy's Laboratories Ltd.NSE: DRREDDY

Press Release Aug 11 2020

· Issued by Dr. Reddy's Laboratories Ltd.

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-11-2020-3

Watch Dr. Reddy's Laboratories' latest callDr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call · Replay · Jul 22Read the transcript of Dr. Reddy's Laboratories (NSE:DRREDDY) Q1 2027 Earnings Call
Dr. Reddy's Laboratories' next earnings callDr. Reddy's Laboratories (NSE:DRREDDY) Q2 2027 Earnings Call · Oct 23, 2026 at 10:00 AM EDTRegister

Dr. Reddy's Laboratories Limited has informed the Exchange regarding a press release dated August 11, 2020, titled "Dr. Reddy's Laboratories announces the First-to-Market launch of the generic version of Ciprodex�� (ciprofloxacin 0.3% and dexamethasone 0.1%) Otic Suspension, USP in the U.S. Market.".

View Attachment

6ix hasn’t read this filing yet.

Dr. Reddy's Laboratories Ltd. on 6ix

Later from Dr. Reddy's Laboratories

All Dr. Reddy's Laboratories news releases